Cargando…

Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells

The purpose of this study was to determine the potential benefits of combination therapy using dimercaptosuccinic acid modified iron oxide (DMSA-Fe(3)O(4)) magnetic nanoparticles (MNPs) combined with nontoxic concentration of bortezomib (BTZ) and gambogic acid (GA) on multiple myeloma (MM) RPMI-8226...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Qiao, Lixing, Wang, Xinchao, Senthilkumar, Ravichandran, Wang, Fei, Chen, Baoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425315/
https://www.ncbi.nlm.nih.gov/pubmed/25995634
http://dx.doi.org/10.2147/IJN.S80795
_version_ 1782370469726388224
author Zhang, Wei
Qiao, Lixing
Wang, Xinchao
Senthilkumar, Ravichandran
Wang, Fei
Chen, Baoan
author_facet Zhang, Wei
Qiao, Lixing
Wang, Xinchao
Senthilkumar, Ravichandran
Wang, Fei
Chen, Baoan
author_sort Zhang, Wei
collection PubMed
description The purpose of this study was to determine the potential benefits of combination therapy using dimercaptosuccinic acid modified iron oxide (DMSA-Fe(3)O(4)) magnetic nanoparticles (MNPs) combined with nontoxic concentration of bortezomib (BTZ) and gambogic acid (GA) on multiple myeloma (MM) RPMI-8226 cells and possible underlying mechanisms. The effects of BTZ-GA-loaded MNP-Fe(3)O(4) (BTZ-GA/MNPs) on cell proliferation were assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,4,-diphenyltetrazolium bromide (MTT) method. Cell cycle and apoptosis were detected using the terminal deoxyribonucleotidyl transferase (TdT)-mediated biotin-16-dUTP nick-end labeling (TUNEL) assay and flow cytometry (FCM). Furthermore, DMSA-Fe(3)O(4) MNPs were characterized in terms of distribution, apoptotic morphology, and cellular uptake by transmission electron microscopy (TEM) and 4,6-diamidino-2-phenylindole (DAPI) staining. Subsequently, the effect of BTZ-GA/MNPs combination on PI3K/Akt activation and apoptotic-related protein were appraised by Western blotting. MTT assay and hematoxylin and eosin (HE) staining were applied to elevate the functions of BTZ-GA/MNPs combination on the tumor xenograft model and tumor necrosis. The results of this study revealed that the majority of MNPs were quasi-spherical and the MNPs taken up by cells were located in the endosome vesicles of cytoplasm. Nontoxic concentration of BTZ-GA/MNPs increased G(2)/M phase cell cycle arrest and induced apoptosis in RPMI-8226 cells. Furthermore, the combination of BTZ-GA/MNPs activated phosphorylated Akt levels, Caspase-3, and Bax expression, and down-regulated the PI3K and Bcl-2 levels significantly. Meanwhile, the in vivo tumor xenograft model indicated that the treatment of BTZ-GA/MNPs decreased the tumor growth and volume and induced cell apoptosis and necrosis. These findings suggest that chemotherapeutic agents polymerized MNPs-Fe(3)O(4) with GA could serve as a better alternative for targeted therapeutic approaches to treat multiple myeloma.
format Online
Article
Text
id pubmed-4425315
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44253152015-05-20 Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells Zhang, Wei Qiao, Lixing Wang, Xinchao Senthilkumar, Ravichandran Wang, Fei Chen, Baoan Int J Nanomedicine Original Research The purpose of this study was to determine the potential benefits of combination therapy using dimercaptosuccinic acid modified iron oxide (DMSA-Fe(3)O(4)) magnetic nanoparticles (MNPs) combined with nontoxic concentration of bortezomib (BTZ) and gambogic acid (GA) on multiple myeloma (MM) RPMI-8226 cells and possible underlying mechanisms. The effects of BTZ-GA-loaded MNP-Fe(3)O(4) (BTZ-GA/MNPs) on cell proliferation were assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,4,-diphenyltetrazolium bromide (MTT) method. Cell cycle and apoptosis were detected using the terminal deoxyribonucleotidyl transferase (TdT)-mediated biotin-16-dUTP nick-end labeling (TUNEL) assay and flow cytometry (FCM). Furthermore, DMSA-Fe(3)O(4) MNPs were characterized in terms of distribution, apoptotic morphology, and cellular uptake by transmission electron microscopy (TEM) and 4,6-diamidino-2-phenylindole (DAPI) staining. Subsequently, the effect of BTZ-GA/MNPs combination on PI3K/Akt activation and apoptotic-related protein were appraised by Western blotting. MTT assay and hematoxylin and eosin (HE) staining were applied to elevate the functions of BTZ-GA/MNPs combination on the tumor xenograft model and tumor necrosis. The results of this study revealed that the majority of MNPs were quasi-spherical and the MNPs taken up by cells were located in the endosome vesicles of cytoplasm. Nontoxic concentration of BTZ-GA/MNPs increased G(2)/M phase cell cycle arrest and induced apoptosis in RPMI-8226 cells. Furthermore, the combination of BTZ-GA/MNPs activated phosphorylated Akt levels, Caspase-3, and Bax expression, and down-regulated the PI3K and Bcl-2 levels significantly. Meanwhile, the in vivo tumor xenograft model indicated that the treatment of BTZ-GA/MNPs decreased the tumor growth and volume and induced cell apoptosis and necrosis. These findings suggest that chemotherapeutic agents polymerized MNPs-Fe(3)O(4) with GA could serve as a better alternative for targeted therapeutic approaches to treat multiple myeloma. Dove Medical Press 2015-04-30 /pmc/articles/PMC4425315/ /pubmed/25995634 http://dx.doi.org/10.2147/IJN.S80795 Text en © 2015 Zhang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhang, Wei
Qiao, Lixing
Wang, Xinchao
Senthilkumar, Ravichandran
Wang, Fei
Chen, Baoan
Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells
title Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells
title_full Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells
title_fullStr Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells
title_full_unstemmed Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells
title_short Inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified Fe(3)O(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in RPMI-8226 cells
title_sort inducing cell cycle arrest and apoptosis by dimercaptosuccinic acid modified fe(3)o(4) magnetic nanoparticles combined with nontoxic concentration of bortezomib and gambogic acid in rpmi-8226 cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425315/
https://www.ncbi.nlm.nih.gov/pubmed/25995634
http://dx.doi.org/10.2147/IJN.S80795
work_keys_str_mv AT zhangwei inducingcellcyclearrestandapoptosisbydimercaptosuccinicacidmodifiedfe3o4magneticnanoparticlescombinedwithnontoxicconcentrationofbortezomibandgambogicacidinrpmi8226cells
AT qiaolixing inducingcellcyclearrestandapoptosisbydimercaptosuccinicacidmodifiedfe3o4magneticnanoparticlescombinedwithnontoxicconcentrationofbortezomibandgambogicacidinrpmi8226cells
AT wangxinchao inducingcellcyclearrestandapoptosisbydimercaptosuccinicacidmodifiedfe3o4magneticnanoparticlescombinedwithnontoxicconcentrationofbortezomibandgambogicacidinrpmi8226cells
AT senthilkumarravichandran inducingcellcyclearrestandapoptosisbydimercaptosuccinicacidmodifiedfe3o4magneticnanoparticlescombinedwithnontoxicconcentrationofbortezomibandgambogicacidinrpmi8226cells
AT wangfei inducingcellcyclearrestandapoptosisbydimercaptosuccinicacidmodifiedfe3o4magneticnanoparticlescombinedwithnontoxicconcentrationofbortezomibandgambogicacidinrpmi8226cells
AT chenbaoan inducingcellcyclearrestandapoptosisbydimercaptosuccinicacidmodifiedfe3o4magneticnanoparticlescombinedwithnontoxicconcentrationofbortezomibandgambogicacidinrpmi8226cells